Differential expression of the human CD8β splice variants and regulation of the M-2 isoform by ubiquitination

Journal of Immunology

Volumn 180, Issue 11, 2008, Pages 7431-7442

  Thakral, Deepshi ^a   Dobbins, Jessica ^a   Devine, Lesley ^b   Kavathas, Paula B ^a,c  

^a Department of Genetics ^*  (United States)

^b YALE CANCER CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE; MESSENGER RNA; CD3 ANTIGEN; CD3 ANTIGEN, ZETA CHAIN; CD8 ANTIGEN; CD8BETA ANTIGEN; HYBRID PROTEIN; ISOPROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CD8+ T LYMPHOCYTE; CD8D GENE; GENE; GENE CONTROL; GENETIC VARIABILITY; HUMAN; LYMPHOCYTE ACTIVATION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA SPLICING; UBIQUITINATION; ADOLESCENT; ADULT; ALTERNATIVE RNA SPLICING; ANIMAL; CELL MEMBRANE; CYTOLOGY; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYSOSOME; METABOLISM; MIDDLE AGED; MOUSE; T LYMPHOCYTE;

ADOLESCENT; ADULT; ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD3; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CELL MEMBRANE; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; LYSOSOMES; MICE; MIDDLE AGED; PROTEIN ISOFORMS; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES; UBIQUITINATION;

EID: 47249130306     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.11.7431     Document Type: Article

References (47)

1. Moebius, U., G. Kober, A. L. Griscelli, T. Hercend, and S. C. Meuer. 1991. Expression of different CD8 isoforms on distinct human lymphocyte subpopula-tions. Eur. J. Immunol. 21: 1793-1800.
2. Norment, A. M., and D. R. Littman. 1988. A second subunit of CDS is expressed in human T cells. EMBO J. 7: 3433-3439.
3. Devine, L., L. J. Kieffer, V. Aitken, and P. B. Kavathas. 2000. Human CDSβ, but not mouse CD8β, can be expressed in the absence of CD8aα as a ββ homodimer. J. Immunol. 164: 833-838.
4. Janeway, C. A., Jr. 1992. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10: 645-674.
5. Straus, D. B., and A. Weiss. 1992. Genetic evidence for the involvement of the Ick tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70: 585-593.
6. Alcover, A., and B. Alarcon. 2000. Intemalization and intracellular fate of TCR-CD3 complexes. Crit. Rev. Immunol. 20: 325-346.
7. Luton, R, V. Legendre, J. P. Gorvel, A. M. Schmitt-Verhulst, and C. Boyer. 1997. Tyrosine and serine protein kinase activities associated with ligand-induced internalized TCR/CD3 complexes. J. Immunol. 158: 3140-3147.
8. Valitutti, S., S. Muller, M. Salio, and A. Lanzavecchia. 1997. Degradation of T cell receptor (TCR)-CD3-ζ complexes after antigenic stimulation. J. Exp. Med. 185: 1859-1864.
9. Crotzer, V. L., A. S. Mabardy, A. Weiss, and F. M. Brodsky. 2004. T cell receptor engagement leads to phosphorylation of clathrin heavy chain during receptor intemalization. J. Exp. Med. 199: 981-991.
10. Cenciarelli, C., D. Hou, K. C. Hsu, B. L. Rellahan, D. L. Wiest, H. T. Smith, V. A. Fried, and A. M. Weissman. 1992. Activation-induced ubiquitination of the T cell antigen receptor. Science 257: 795-797.
11. Myers, M. D., T. Sosinowski, L. L. Dragone, C. White, H. Band, H. Gu, and A. Weiss. 2006. Src-like adaptor protein regulates TCR expression on thymocytes by linking the ubiquitin ligase c-Cbl to the TCR complex. Nat. Immunol. 7: 57-66.
12. Couedel, C., M. Bodinier, M. A. Peyrat, M. Bonneville, F. Davodeau, and F. Lang. 1999. Selection and long-term persistence of reactive CTL clones during an EBV chronic response are determined by avidity, CD8 variable contribution compensating for differences in TCR affinities. J. Immunol. 162: 6351-6358.
13. + T lymphocytes involving loss of tetramer labeling. Eur. J. Immunol. 32: 1688-1697.
14. Kao, C., M. A. Daniels, and S. C. Jameson. 2005. Loss of CD8 and TCR binding to class I MHC ligands following T cell activation. Int. Immunol. 17: 1607-1617.
15. Maile, R., C. A. Siler, S. E. Kerry, K. E. Midkiff, E. J. Collins, and J. A. Frelinger. 2005. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo. J. Immunol. 174: 619-627.
16. Cawthon, A. G., H. Lu, and M. A. Alexander-Miller. 2001. Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement: correlation with CD8αβ versus CD8αα expression. J. Immunol. 167: 2577-2584.
17. Hoeveler, A., and B. Malissen. 1993. The cysteine residues in the cytoplasmic tail of CD8α are required for its coreceptor function. Mol. Immunol. 30: 755-764.
18. Shaw, A. S., J. Chalupny, J. A. Whitney, C. Hammond, K. E. Amrein, P. Kavathas, B. M. Sefton, and J. K. Rose. 1990. Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p561ck tyrosine protein kinase. Mol. Cell. Biol. 10: 1853-1862.
19. Veillette, A., M. A. Bookman, E. M. Horak, and J. B. Bolen. 1988. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p561ck. Cell 55: 301-308.
20. Arcaro, A., C. Gregoire, N. Boucheron, S. Stotz, E. Palmer, B. Malissen, and I. F. Luescher. 2000. Essential role of CD8 palmitoylation in CD8 coreceptor function. J. Immunol. 165: 2068-2076.
21. Irie, H. Y., K. S. Ravichandran, and S. J. Burakoff. 1995. CD8 beta chain influences CDS alpha chain-associated Lck kinase activity. J. Exp. Med. 181: 1267-1273.
22. + T cells in the thymus. Immunity 12: 409-418.
23. Crooks, M. E., and D. R. Littman. 1994. Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 beta chain. Immunity 1: 277-285.
24. Itano, A., D. Cado, F. K. Chan, and E. Robey. 1994. A role for the cytoplasmic tail of the beta chain of CD8 in thymic selection. Immunity 1: 287-290.
25. Nakayama, K., K. Nakayama, I. Negishi, K. Kuida, M. C. Louie, O. Kanagawa, H. Nakauchi, and D. Y. Loh. 1994. Requirement for CD8 beta chain in positive selection of CD8-lineage T cells. Science 263: 1131-1133.
26. Doucey, M. A., L. Goffin, D. Naeher, O. Michielin, P. Baumgartner, P. Guillaume, E. Palmer, and I. F. Luescher. 2003. CD3S establishes a functional link between the T cell receptor and CDS. J. Biol. Chem. 278: 3257-3264.
27. Daniels, M. A., L. Devine, J. D. Miller, J. M. Moser, A. E. Lukacher, J. D. Altman, P. Kavathas, K. A. Hogquist, and S. C. Jameson. 2001. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 15: 1051-1061.
28. Moody, A. M., D. Chui, P. A. Reche, J. J. Priatel, J. D. Marth, and E. L. Reinherz. 2001. Developmentally regulated glycosylation of the CD8αβ coreceptor stalk modulates ligand binding. Cell 107: 501-512.
29. DiSanto, J. P., D. Smith, D. de Bruin, E. Lacy, and N. Flomenberg. 1993. Transcriptional diversity at the duplicated human CD8 beta loci. Eur. J. Immunol. 23: 320-326.
30. Nakayama, K., Y. Kawachi, S. Tokito, N. Minami, R. Yamamoto, T. Imai, G. Gachelin, and H. Nakauchi. 1992. Recent duplication of the two human CD8 beta-chain genes. J. Immunol. 148: 1919-1927.
31. Shiue, L., S. D. Gorman, and J. R. Parnes. 1988. A second chain of human CD8 is expressed on peripheral blood lymphocytes. J. Exp. Med. 168: 1993-2005.
32. Pang, D. J., A. C. Hayday, and M. J. Bijlmakers. 2007. CD8 raft localization is induced by its assembly into CD8αβ heterodimers, not CD8αα homodimers. J. Biol. Chem. 282: 13884-13894.
33. Yachi, P. P., J. Ampudia, N. R. Gascoigne, and T. Zal. 2005. Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse. Nat. Immunol. 6: 785-792.
34. Devine, L., D. Thakral, S. Nag, J. Dobbins, M. E. Hodsdon, and P. B. Kavathas. 2006. Mapping the binding site on CD8β for MHC class I reveals mutants with enhanced binding. J. Immunol. 177: 3930-3938.
35. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745-763.
36. Werwitzke, S., A. Tiede, B. E. Drescher, R. E. Schmidt, and T. Witte. 2003. CD8β/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes. Clin. Exp. Immunol. 133: 334-343.
37. Yachi, P. P., J. Ampudia, T. Zal, and N. R. Gascoigne. 2006. Altered peptide ligands induce delayed CD8-T cell receptor interaction: a role for CD8 in distinguishing antigen quality. Immunity 25: 203-211.
38. Haglund, K., P. P. Di Fiore, and I. Dikic. 2003. Distinct monoubiquitin signals in receptor endocytosis. Trends Biochem. Sci. 28: 598-603.
39. Hicke, L., and R. Dunn. 2003. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu. Rev. Cell. Dev. Biol. 19: 141-172.
40. Wang, G. S., and T. A. Cooper. 2007. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat. Rev. Genet. 8: 749-761.
41. Sorek, R. 2007. The birth of new exons: mechanisms and evolutionary consequences. RNA 13: 1603-1608.
42. Xing, Y., and C. Lee. 2006. Alternative splicing and RNA selection pressure: evolutionary consequences for eukaryotic genomes. Nat. Rev. Genet. 7: 499-509.
43. Songyang, Z., S. E. Shoelson, J. McGlade, P. Olivier, T. Pawson, X. R. Bustelo, M. Barbacid, H. Sabe, H. Hanafusa, T. Yi, et al. 1994. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14: 2777-2785.
44. Dietrich, J., X. Hou, A. M. Wegener, and C. Geisler. 1994. CD3γ contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J. 13: 2156-2166.
45. Shin, J. S., M. Ebersold, M. Pypaert, L. Delamarre, A. Hartley, and I. Mellman. 2006. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444: 115-118.
46. Laugel, B., D. A. Price, A. Milicic, and A. K. Sewell. 2007. CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions. Eur. J. Immunol. 37: 905-913.
47. + T cell differentiation during viral infection. Immunity 27: 393-405.